BioSpace News Archive

Bioasis Technologies Inc. announced it has filed its audited annual financial statements and management’s discussion and analysis for the period ended August 31, 2019.

Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced that the Company is scheduled to release its financial results for the third quarter ended September 30, 2019 on Wednesday, October 30, 2019, after the U.S. stock markets close.

10x Genomics announced it will report financial results for the third quarter 2019 after market close on Thursday, November 7, 2019.

The Florida State University College of Medicine Family Medicine Residency at BayCare Health System has received accreditation from the Accreditation Council for Graduate Medical Education

Atara Biotherapeutics, Inc. announced the departures of Dr. Christopher Haqq, Chief Scientific Officer, and Mina Kim, General Counsel and Head of Corporate Strategy.

Closure May Lead to Medical Device Shortage & Impact Patients

Mylan Pharmaceuticals Inc. is conducting a voluntary nationwide recall of one lot of Alprazolam Tablets, USP C-IV 0.5 mg, to the consumer/user level.

Doheny Eye Institute has announced that Charles T. Foscue has been elected as Chairman of the DEI Board of Directors. Mr. Foscue was preceded by Edward A. Landry, who served as chairman for 20 years prior to retiring from the Board in September..